Loading market data...
Latest Top News
Show more
Neuland Laboratories Posts Robust Q3 Earnings with ₹4.4 Billion Revenue
Neuland Laboratories Ltd announced its December quarter results, reporting consolidated revenue of ₹4.4 billion and a net profit of ₹405.7 million. The performance underscores the company’s strength in pharmaceutical manufacturing and API exports, driven by operational efficiency and steady demand across global healthcare markets.
Stay Ahead – Explore Now! India Optimistic on FY 2025-26 Growth Rate Forecast Despite Oil and Tariff Issues






